Loading the map…
General medical practice activities · Stamford, Lincolnshire
Innovative Medicine
Innovative Medicine Limited
Private limited company registered in Stamford, classed under “General medical practice activities”.
Headline figures
FY to Jun 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
1 finding from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Profit after tax | — | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current assets | ||||
| of which cash | ||||
| Net current assets | ||||
| Net assets |
4 balance-sheet lines, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Innovative Medicine do?
Private limited company registered in Stamford, classed under “General medical practice activities”.
›How much turnover does Innovative Medicine make?
Answered in the full report
›Is Innovative Medicine profitable?
Innovative Medicine's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Innovative Medicine?
Answered in the full report
›Where is Innovative Medicine based?
Its registered office is 85a Main Road, Collyweston, Stamford, Lincolnshire, PE9 3PQ, in Stamford, Lincolnshire.
›When was Innovative Medicine founded?
Innovative Medicine Limited was incorporated on 15 June 2016.
›Is Innovative Medicine still trading?
The register lists Innovative Medicine Limited as active.